BioCentury | Jul 26, 2019
Preclinical News

July 26 preclinical Quick Takes: Ribon's new mechanism for PARP inhibitors, a microbiome-ALS link and more

...Staff Writers BMS-986165 BiomX Ltd. Bristol-Myers Squibb Co. Cytokinetics Inc. DayTwo Ltd. NanoString Technologies Inc. Ribon Therapeutics Inc. University of Texas Southwestern Medical Center Vanderbilt-Ingram Cancer Center DEAD...
BioCentury | Mar 8, 2018
Company News

Reed leaving Roche's pRED division

...2014, was previously a professor at Vanderbilt University and director of personalized cancer medicine at Vanderbilt-Ingram Cancer Center. Chris...
BioCentury | Jan 12, 2017
Company News

American Association for Cancer Research genomics news

...Margaret Cancer Centre (Toronto, Ontario); University of Texas MD Anderson Cancer Center (Houston, Texas); and Vanderbilt-Ingram Cancer Center...
...Roussy Memorial Sloan Kettering Cancer Center Netherlands Cancer Institute The Johns Hopkins University University of Texas MD Anderson Cancer Center Vanderbilt-Ingram Cancer Center Princess...
BioCentury | Jan 6, 2017
Clinical News

AACR releases Project GENIE data

...Center ; Princess Margaret Cancer Centre; University of Texas MD Anderson Cancer Center ; and Vanderbilt-Ingram Cancer Center...
...Roussy Memorial Sloan Kettering Cancer Center Netherlands Cancer Institute The Johns Hopkins University University of Texas MD Anderson Cancer Center Vanderbilt-Ingram Cancer Center Project...
BioCentury | Jun 13, 2016
Product Development

Triple's shot

...part of hormone signaling, Vandana Abramson, a medical oncologist and associate professor of medicine at Vanderbilt-Ingram Cancer Center...
...Carbone Cancer Center, Madison, Wis. U.S. Food and Drug Administration (FDA) , Silver Spring, Md. Vanderbilt-Ingram Cancer Center...
BioCentury | Mar 24, 2016
Strategy

Combo platter

...an associate professor of medicine and director of the Hematology Early Therapeutics Program at the Vanderbilt-Ingram Cancer Center...
...Lexington, Mass. American Association for Cancer Research (AACR), Philadelphia, Pa. Incyte Corp. (NASDAQ:INCY), Wilmington, Del. Vanderbilt-Ingram Cancer Center...
BioCentury | Nov 7, 2015
Clinical News

AACR starts genomics initiative

...Kimmel Comprehensive Cancer Center; Memorial Sloan Kettering Cancer Center ; Princess Margaret Cancer Centre; and Vanderbilt-Ingram Cancer Center...
BioCentury | Oct 26, 2015
Company News

Opko Health Inc, Vanderbilt University, Vanderbilt-Ingram Cancer Center deal

...to inquiries. Opko Health Inc . (NYSE:OPK;Tel Aviv:OPK), Miami, Fla. Vanderbilt University , Nashville, Tenn. Vanderbilt-Ingram Cancer Center...
BioCentury | Oct 22, 2015
Distillery Therapeutics

Therapeutics: Delta-like 1 (DLL1); immunoglobulin G (IgG)

...Cancer Res.; published online Sept. 24, 2015 doi:10.1158/0008-5472.CAN-14-1154 CONTACT: Anil Shanker, Meharry Medical College and Vanderbilt-Ingram Cancer Center...
BioCentury | Oct 15, 2015
Finance

Public-Private Partnership Roundup

...and CSO of Incyte, and Michael Savona, director of the Hematology Early Therapy Program at Vanderbilt-Ingram Cancer Center...
Items per page:
1 - 10 of 19
BioCentury | Jul 26, 2019
Preclinical News

July 26 preclinical Quick Takes: Ribon's new mechanism for PARP inhibitors, a microbiome-ALS link and more

...Staff Writers BMS-986165 BiomX Ltd. Bristol-Myers Squibb Co. Cytokinetics Inc. DayTwo Ltd. NanoString Technologies Inc. Ribon Therapeutics Inc. University of Texas Southwestern Medical Center Vanderbilt-Ingram Cancer Center DEAD...
BioCentury | Mar 8, 2018
Company News

Reed leaving Roche's pRED division

...2014, was previously a professor at Vanderbilt University and director of personalized cancer medicine at Vanderbilt-Ingram Cancer Center. Chris...
BioCentury | Jan 12, 2017
Company News

American Association for Cancer Research genomics news

...Margaret Cancer Centre (Toronto, Ontario); University of Texas MD Anderson Cancer Center (Houston, Texas); and Vanderbilt-Ingram Cancer Center...
...Roussy Memorial Sloan Kettering Cancer Center Netherlands Cancer Institute The Johns Hopkins University University of Texas MD Anderson Cancer Center Vanderbilt-Ingram Cancer Center Princess...
BioCentury | Jan 6, 2017
Clinical News

AACR releases Project GENIE data

...Center ; Princess Margaret Cancer Centre; University of Texas MD Anderson Cancer Center ; and Vanderbilt-Ingram Cancer Center...
...Roussy Memorial Sloan Kettering Cancer Center Netherlands Cancer Institute The Johns Hopkins University University of Texas MD Anderson Cancer Center Vanderbilt-Ingram Cancer Center Project...
BioCentury | Jun 13, 2016
Product Development

Triple's shot

...part of hormone signaling, Vandana Abramson, a medical oncologist and associate professor of medicine at Vanderbilt-Ingram Cancer Center...
...Carbone Cancer Center, Madison, Wis. U.S. Food and Drug Administration (FDA) , Silver Spring, Md. Vanderbilt-Ingram Cancer Center...
BioCentury | Mar 24, 2016
Strategy

Combo platter

...an associate professor of medicine and director of the Hematology Early Therapeutics Program at the Vanderbilt-Ingram Cancer Center...
...Lexington, Mass. American Association for Cancer Research (AACR), Philadelphia, Pa. Incyte Corp. (NASDAQ:INCY), Wilmington, Del. Vanderbilt-Ingram Cancer Center...
BioCentury | Nov 7, 2015
Clinical News

AACR starts genomics initiative

...Kimmel Comprehensive Cancer Center; Memorial Sloan Kettering Cancer Center ; Princess Margaret Cancer Centre; and Vanderbilt-Ingram Cancer Center...
BioCentury | Oct 26, 2015
Company News

Opko Health Inc, Vanderbilt University, Vanderbilt-Ingram Cancer Center deal

...to inquiries. Opko Health Inc . (NYSE:OPK;Tel Aviv:OPK), Miami, Fla. Vanderbilt University , Nashville, Tenn. Vanderbilt-Ingram Cancer Center...
BioCentury | Oct 22, 2015
Distillery Therapeutics

Therapeutics: Delta-like 1 (DLL1); immunoglobulin G (IgG)

...Cancer Res.; published online Sept. 24, 2015 doi:10.1158/0008-5472.CAN-14-1154 CONTACT: Anil Shanker, Meharry Medical College and Vanderbilt-Ingram Cancer Center...
BioCentury | Oct 15, 2015
Finance

Public-Private Partnership Roundup

...and CSO of Incyte, and Michael Savona, director of the Hematology Early Therapy Program at Vanderbilt-Ingram Cancer Center...
Items per page:
1 - 10 of 19